synovial sarcoma

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

Recruiting
  • Ewing Sarcoma
  • +2 more
  • Peptide vaccine IPX
  • Frankfurt am Main, Germany
  • +2 more
Oct 18, 2023

Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

Not yet recruiting
  • Synovial Sarcoma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Synovial Sarcoma Trial in Philadelphia

Recruiting
  • Synovial Sarcoma
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 21, 2023

    Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

    Not yet recruiting
    • Breast Cancer Metastatic
    • +7 more
    • Denver, Colorado
    • +1 more
    Apr 28, 2023

    Synovial Sarcoma, Soft Tissue Sarcoma Trial in United States (CFT8634)

    Recruiting
    • Synovial Sarcoma
    • Soft Tissue Sarcoma
    • Duarte, California
    • +12 more
    Feb 2, 2023

    Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

    Active, not recruiting
    • Malignant Rhabdoid Tumors (MRT)
    • +10 more
    • San Francisco, California
    • +31 more
    Jan 17, 2023

    Synovial Sarcoma, Myxoid Liposarcoma Trial in Worldwide (afamitresgene autoleucel (previously ADP-A2M4))

    Recruiting
    • Synovial Sarcoma
    • Myxoid Liposarcoma
    • afamitresgene autoleucel (previously ADP-A2M4)
    • Duarte, California
    • +26 more
    Dec 7, 2022

    Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

    Not yet recruiting
    • Synovial Sarcoma
    • +3 more
    • Afamitresgene autoleucel
    • Palo Alto, California
    • +3 more
    Dec 6, 2022

    Synovial Sarcoma Trial in Worldwide (Ramucirumab, Gemcitabine, Docetaxel)

    Suspended
    • Synovial Sarcoma
    • Birmingham, Alabama
    • +55 more
    Nov 23, 2022

    Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

    Active, not recruiting
    • Alveolar Soft Part Sarcoma
    • +3 more
    • Phoenix, Arizona
    • +22 more
    Nov 1, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

    Temporarily not available
    • Epithelioid Sarcoma (Ex-US Only)
    • +19 more
    • (no location specified)
    Oct 17, 2022

    Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

    Active, not recruiting
    • Urinary Bladder Cancer
    • +9 more
    • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
    • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
    • Miami, Florida
    • +10 more
    Aug 9, 2022

    Ewing Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (PRT2527)

    Recruiting
    • Ewing Sarcoma
    • +7 more
    • Denver, Colorado
    • +5 more
    Jun 9, 2022

    All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

    Active, not recruiting
    • All Malignancies
    • +11 more
    • Encinitas, California
    • +9 more
    May 20, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

    Recruiting
    • Leiomyosarcoma
    • +29 more
    • Definitive Surgical Resection
    • +3 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Apr 26, 2022

    Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

    Recruiting
    • Soft Tissue Sarcoma Adult
    • +6 more
    • Bordeaux, France
      Institut Bergonie
    Feb 1, 2022

    Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

    Completed
    • Rhabdoid Tumors
    • +3 more
    • Los Angeles, California
    • +34 more
    Dec 23, 2021

    Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

    Withdrawn
    • Soft Tissue Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2021

    Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

    Withdrawn
    • Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Jul 26, 2021

    Synovial Sarcoma Trial in New York (ipilimumab)

    Terminated
    • Synovial Sarcoma
    • ipilimumab
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 23, 2021

    Synovial Sarcoma, Single or Multiple Lung Metastases Trial in United States (Whole Lung IMRT)

    Completed
    • Synovial Sarcoma
    • Single or Multiple Lung Metastases
    • Whole Lung IMRT
    • Basking Ridge, New Jersey
    • +4 more
    Jun 7, 2021

    Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)

    Active, not recruiting
    • Sarcoma
    • +10 more
    • Hypofractionated radiotherapy
    • Hyperthermia
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 27, 2021

    Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

    Unknown status
    • Sarcoma
    • +16 more
    • Sequential chemotherapy - 3 courses of AI
    • Hypofractionated radiotherapy
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 19, 2021